Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Lieberman

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 6, 2007
Inflammatory dural masses: if it's not one thing, it's anotherAndrew P Lieberman
Experimental Neurology|January 23, 2004
SUMO, a ubiquitin-like modifier implicated in neurodegenerationAndrew P Lieberman
Handbook of Clinical Neurology|February 27, 2018
Spinal and bulbar muscular atrophyAndrew P Lieberman
Expert Opinion on Therapeutic Targets|February 7, 2025
Therapeutic targeting of the polyglutamine androgen receptor in Spinal and Bulbar Muscular AtrophyAgamjot Sangotra, Andrew P Lieberman
Plos Genetics|April 18, 2013
Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelinTing Yu, Andrew P Lieberman
Cellular and Molecular Life Sciences : CMLS|May 19, 2016
Polyglutamine androgen receptor-mediated neuromuscular diseaseElisa Giorgetti, Andrew P Lieberman
CNS & Neurological Disorders Drug Targets|September 18, 2013
Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophyJason P Chua, Andrew P Lieberman
Expert Reviews in Molecular Medicine|September 11, 2008
The pathogenesis of Niemann-Pick type C disease: a role for autophagy?Chris D Pacheco, Andrew P Lieberman
Journal of Alzheimer'S Disease : JAD|June 19, 2008
The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancerAndrew P Lieberman, Diane M Robins
Cell Metabolism|March 8, 2018
High Cholesterol at the Heart of Phagolysosomal DamageAndrew P Lieberman, Joel A Swanson
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|June 6, 2007
Inflammatory dural masses: if it's not one thing, it's anotherAndrew P Lieberman
Experimental Neurology|January 23, 2004
SUMO, a ubiquitin-like modifier implicated in neurodegenerationAndrew P Lieberman
Handbook of Clinical Neurology|February 27, 2018
Spinal and bulbar muscular atrophyAndrew P Lieberman
Expert Opinion on Therapeutic Targets|February 7, 2025
Therapeutic targeting of the polyglutamine androgen receptor in Spinal and Bulbar Muscular AtrophyAgamjot Sangotra, Andrew P Lieberman
Plos Genetics|April 18, 2013
Npc1 acting in neurons and glia is essential for the formation and maintenance of CNS myelinTing Yu, Andrew P Lieberman
Cellular and Molecular Life Sciences : CMLS|May 19, 2016
Polyglutamine androgen receptor-mediated neuromuscular diseaseElisa Giorgetti, Andrew P Lieberman
CNS & Neurological Disorders Drug Targets|September 18, 2013
Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophyJason P Chua, Andrew P Lieberman
Expert Reviews in Molecular Medicine|September 11, 2008
The pathogenesis of Niemann-Pick type C disease: a role for autophagy?Chris D Pacheco, Andrew P Lieberman
Journal of Alzheimer'S Disease : JAD|June 19, 2008
The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancerAndrew P Lieberman, Diane M Robins
Cell Metabolism|March 8, 2018
High Cholesterol at the Heart of Phagolysosomal DamageAndrew P Lieberman, Joel A Swanson
Pageof 15